Pilot study evaluates CMS classification in colorectal cancer, suggesting potential for personalized treatment.
Background: The consensus molecular subtype (CMS) classification stratifies colorectal cancer (CRC) into four groups based on gene expression, offering potential for tailored therapy. This study evaluated the feasibility of CMS classification using preoperative biopsy specimens.
No takes yet. Share an insight, caveat, or question.
Kasai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: